Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system-Reference-Cited by-同舟云学术

Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system

Published:2015-05-20 Issue:2 Volume:80 Page:285-293
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Raschi Emanuel¹,Poluzzi Elisabetta¹,Koci Ariola¹,Salvo Francesco²³,Pariente Antoine²³⁴,Biselli Maurizio¹,Moretti Ugo⁵,Moore Nicholas²³⁴^ORCID,De Ponti Fabrizio¹

Affiliation:

1. Department of Medical and Surgical Sciences; University of Bologna; Bologna Italy

2. University of Bordeaux, U657; F33000 Bordeaux France

3. INSERM U657; F33000 Bordeaux France

4. CIC Bordeaux CIC1401; F33000 Bordeaux France

5. Department of Public Health and Community Medicine; University of Verona; Verona Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12611/fullpdf

Reference43 articles.

1. Clinical features, diagnosis, and natural history of drug-induced liver injury;Hayashi;Semin Liver Dis,2014

2. Drug-induced liver injury throughout the drug development life cycle: Where we have been, where we are now, and where we are headed. Perspectives of a clinical hepatologist;Lewis;Pharmaceut Med,2013

3. Postmarketing safety surveillance: where does signal detection using electronic healthcare records fit into the big picture?;Coloma;Drug Saf,2013

4. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system;Harpaz;Clin Pharmacol Ther,2013

5. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA adverse event reporting system (FAERS) database;Brinker;Drug Saf,2013

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's Adverse Event Reporting System dataset;Journal of the American Academy of Dermatology;2024-07

2. Machine Learning to Predict Drug-Induced Liver Injury and Its Validation on Failed Drug Candidates in Development;Toxics;2024-05-24

3. Comparators in Pharmacovigilance: A Quasi-Quantification Bias Analysis;Drug Safety;2024-05-04

4. Case report: Severe hepatopathy following rivaroxaban administration in a dog;Frontiers in Veterinary Science;2024-04-04

5. Machine Learning to Predict Drug-Induced Liver Injury and its Validation on Failed Drug Candidates in Development;2024-03-20